The IMGF offers assays that evaluate the presence of immune cells with specific anti-tumor activity.
The IMGF focuses on the preparation of Next Generation Sequencing Libraries of immune cells and solid tumor and non-tumor tissues.
Immune cell phenotypes are determined by labeling with panels of fluorophore- or nanoparticle-conjugated antibodies and subsequent analysis by fluorescence flow cytometry or time of flight mass cytometry.